High yield synthesis, purification and characterisation of the RNase L activators 5'-triphosphate 2′-5′-oligoadenylates

Antiviral Research

Volumn 87, Issue 3, 2010, Pages 345-352

  Morin, B ^a   Rabah, N ^a   Boretto Soler, J ^a   Tolou, H ^b   Alvarez, K ^a   Canard, B ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

2 5 Oligoadenylate; Antiviral; HPLC; Oligoadenylate synthetase; Ribonuclease L

Indexed keywords

2',5' OLIGOADENYLATE 5' TRIPHOSPHATE; 2',5' OLIGOADENYLIC ACID; ALKALINE PHOSPHATASE; ANTIVIRUS AGENT; RIBONUCLEASE L; RIBOSOME RNA; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG PURIFICATION; DRUG SYNTHESIS; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSECT CELL; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RNA CAPPING; RNA CLEAVAGE; RNA DEGRADATION; STRUCTURE ANALYSIS; VACCINIA VIRUS;

SUS;

EID: 77955846572     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.06.003     Document Type: Article

References (36)

1. Behera A.K., Kumar M., Lockey R.F., Mohapatra S.S. 2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. J. Biol. Chem. 2002, 277(28):25601-25608.
2. Budowsky E.I., Kayushina E.N., Tarasov A.K., Orlenko S.A., Cherkasov I.A., Gavrilov A.E., Strelenko Y.A. Preparation of cyclic 2',3'-monophosphates of oligoadenylates (A2'p)nA>p and A3'p(A2'p)n-1A>p. Eur. J. Biochem. 1994, 220(1):97-104.
3. Dong B., Silverman R.H. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 1995, 270(8):4133-4137.
4. Dong B., Silverman R.H. A bipartite model of 2-5A-dependent RNase L. J. Biol. Chem. 1997, 272(35):22236-22242.
5. Han J.Q., Townsend H.L., Jha B.K., Paranjape J.M., Silverman R.H., Barton D.J. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. J. Virol. 2007, 81(11):5561-5572.
6. Hartmann R., Justesen J., Sarkar S.N., Sen G.C., Yee V.C. Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase. Mol. Cell. 2003, 12(5):1173-1185.
7. Hovanessian A.G., Justesen J. The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation. Biochimie 2007, 89(6-7):779-788.
8. Imai J., Torrence P.F. An efficient chemical synthesis of adenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine [(2'-5')-oligo(A)]. Methods Enzymol. 1981, 79(Pt B):233-244.
9. Justesen J., Ferbus D., Thang M.N. 2'5' oligoadenylate synthetase, an interferon induced enzyme: direct assay methods for the products, 2'5' oligoadenylates and 2'5' co-oligonucleotides. Nucleic Acids Res. 1980, 8(14):3073-3085.
10. Kajaste-Rudnitski A., Mashimo T., Frenkiel M.P., Guenet J.L., Lucas M., Despres P. The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. J. Biol. Chem. 2006, 281(8):4624-4637.
11. Kim E.E., Wyckoff H.W. Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis. J. Mol. Biol. 1991, 218(2):449-464.
12. Kitade Y., Nakata Y., Hirota K., Maki Y., Pabuccuoglu A., Torrence P.F. 8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities. Nucleic Acids Res. 1991, 19(15):4103-4108.
13. Kodym R., Kodym E., Story M.D. 2'-5'-Oligoadenylate synthetase is activated by a specific RNA sequence motif. Biochem. Biophys. Res. Commun. 2009, 388(2):317-322.
14. Lesiak K., Imai J., Floyd-Smith G., Torrence P.F. Biological activities of phosphodiester linkage isomers of 2-5A. J. Biol. Chem. 1983, 258(21):13082-13088.
15. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448(7155):816-819.
16. Marie I., Blanco J., Rebouillat D., Hovanessian A.G. 69-kDa and 100-kDa isoforms of interferon-induced (2'-5') oligoadenylate synthetase exhibit differential catalytic parameters. Eur. J. Biochem. 1997, 248(2):558-566.
17. Min J.Y., Krug R.M. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(18):7100-7105.
18. Nakanishi M., Tanaka N., Mizutani Y., Mochizuki M., Ueno Y., Nakamura K.T., Kitade Y. Functional characterization of 2',5'-linked oligoadenylate binding determinant of human RNase L. J. Biol. Chem. 2005, 280(50):41694-41699.
19. Rebouillat D., Hovanessian A.G. The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J. Interferon Cytokine Res. 1999, 19(4):295-308.
20. Rebouillat D., Hovnanian A., Marie I., Hovanessian A.G. The 100-kDa 2',5'-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2'p5'A molecules is composed of three homologous domains. J. Biol. Chem. 1999, 274(3):1557-1565.
21. Roberts W.K., Hovanessian A., Brown R.E., Clemens M.J., Kerr I.M. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature 1976, 264(5585):477-480.
22. Rusch L., Dong B., Silverman R.H. Monitoring activation of ribonuclease L by 2',5'-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells. Methods Enzymol. 2001, 342:10-20.
23. Rushizky G.W., Sober H.A. Studies on the specificity of ribonuclease T2. J. Biol. Chem. 1963, 238:371-376.
24. Sarkar S.N., Sen G.C. Production, purification, and characterization of recombinant 2', 5'-oligoadenylate synthetases. Methods 1998, 15(3):233-242.
25. Sawicki D.L., Silverman R.H., Williams B.R., Sawicki S.G. Alphavirus minus-strand synthesis and persistence in mouse embryo fibroblasts derived from mice lacking RNase L and protein kinase R. J. Virol. 2003, 77(3):1801-1811.
26. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 2001, 55:255-281.
27. Servant M.J., Grandvaux N., Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem. Pharmacol. 2002, 64(5-6):985-992.
28. Shuman S. Catalytic activity of vaccinia mRNA capping enzyme subunits coexpressed in Escherichia coli. J. Biol. Chem. 1990, 265(20):11960-11966.
29. Silverman R.H. A scientific journey through the 2-5A/RNase L system. Cytokine Growth Factor Rev. 2007, 18(5-6):381-388.
30. Silverman R.H. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 2007, 81(23):12720-12729.
31. Smith J.A., Schmechel S.C., Williams B.R., Silverman R.H., Schiff L.A. Involvement of the interferon-regulated antiviral proteins PKR and RNase L in reovirus-induced shutoff of cellular translation. J. Virol. 2005, 79(4):2240-2250.
32. Tanaka N., Nakanishi M., Kusakabe Y., Goto Y., Kitade Y., Nakamura K.T. Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L. Embo J. 2004, 23(20):3929-3938.
33. Thakur C.S., Jha B.K., Dong B., Das Gupta J., Silverman K.M., Mao H., Sawai H., Nakamura A.O., Banerjee A.K., Gudkov A., Silverman R.H. Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(23):9585-9590.
34. Xiang Y., Condit R.C., Vijaysri S., Jacobs B., Williams B.R., Silverman R.H. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J. Virol. 2002, 76(10):5251-5259.
35. Xiang Y., Wang Z., Murakami J., Plummer S., Klein E.A., Carpten J.D., Trent J.M., Isaacs W.B., Casey G., Silverman R.H. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates. Cancer Res. 2003, 63(20):6795-6801.
36. Xiao W., Player M.R., Li G., Zhang W., Lesiak K., Torrence P.F. Synthesis and characterization of composite nucleic acids containing 2', 5'-oligoriboadenylate linked to antisense DNA. Antisense Nucleic Acid Drug Dev. 1996, 6(4):247-258.